Research use only. Not for human or animal consumption.La Jolla, CaliforniaLot lookupContact
MAROGENBIO

Format guide

NAD+, MOTS-c, Wolverine and KLOW pens

Four prefilled research pens carrying one to four molecules each. What is in every cartridge, which contents are published and which are not, and what documentation to require for a blend.

Catalog formats covered
4
Papers cited
4
Last reviewed
2026-11-12
Classification
Research use only
Buying this material?
Apply for wholesale pricing
01

What is in each cartridge

Published chemistry for the fills, not a measurement from any lot.

These four span the range of what a prefilled cartridge can hold. The NAD+ pen is a single molecule that is not a peptide at all: nicotinamide adenine dinucleotide, a dinucleotide coenzyme, CAS 53-84-9, 663.4 g/mol. The MOTS-c pen holds one peptide, the 16-residue mitochondrial-derived MRWQEMGYIFYPRKLR at 2174.6 g/mol.

The other two are blends. Wolverine pairs BPC-157, the 15-residue GEPPPGKPADDAGLV at 1419.5 g/mol, with the TB-500 fragment Ac-LKKTETQ at 889. KLOW puts four molecules in one cartridge: GHK-Cu, BPC-157, the TB-500 fragment and KPV. That makes it the most analytically demanding item in the range, because one chromatogram has to resolve a copper complex at 401.9 g/mol, a tripeptide at 342.4, a heptapeptide at 889 and a pentadecapeptide at 1419.5.

02

The four pens as listed

Read directly from the catalog.

Two of the four publish a content and two do not. The NAD+ pen is listed at 500 mg and the Wolverine pen at 10 mg each of its two components, which Marogen's verification record flags as needing confirmation against a certificate. The MOTS-c and KLOW pens are listed with no strength.

None publishes a concentration, a fill volume or a vehicle, and neither blend publishes a per-component split. Every one also exists as a vial, and MOTS-c as a nasal spray too, so for any method needing a concentration the lab sets, the vial is the format to buy.

Catalog formats covered by this guide
ListingFormSizesSKUDocumentation
KLOWPrefilled research penNot publishedPEN-KLOWNot yet published
MOTS-CPrefilled research penNot publishedPEN-MOTSNot yet published
NAD+Prefilled research pen500 mgPEN-NAD-500Not yet published
WolverinePrefilled research pen10+10 mgPEN-WOLV-20Not yet published

4 catalog listings are covered here. Sizes, SKUs and documentation status are read from the catalog at build time. Blends contain more than one molecule, so only single-component listings behave as a single-analyte standard. Pricing is per account: see wholesale pricing.

03

Which figures are published and which are not

The gap between a box strength and a specification.

A box strength looks like a specification and is not one. What Marogen publishes is a product name, a SKU, and in two cases a total milligram figure. It does not publish the concentration, the fill volume, the vehicle, or how a blend's total divides between components.

For the blends that gap is larger than it looks. A total without a ratio is close to uninformative: KLOW's four components could be in any proportion and the box would read the same. If the ratio matters, it has to come from the lot's certificate, reported per component.

Which figures are published and which are not
PenWhat the catalog publishes
NAD+ pen500 mg total content. No concentration, fill volume or vehicle
MOTS-c penNo published strength, concentration, fill volume or vehicle
Wolverine pen10 mg of each per the catalog copy, flagged as needing confirmation
KLOW penNo published strength and no split across its four molecules
All fourNo vehicle stated, which affects stability and dilution
04

Identification and documentation

A blend certificate has to do four jobs, not one.

For the two single-component pens, identification is ordinary: one calculated mass, one observed mass, one purity figure, one content figure. NAD+ is the exception, because it absorbs near 260 nm rather than the 214 or 220 nm used for peptides, so the wavelength has to match the analyte.

For Wolverine and KLOW, a single purity percentage is not a usable measurement. The certificate needs a mass, a purity figure and a content figure per molecule, two sets for Wolverine and four for KLOW. The TB-500 component carries an open question the published Wolverine vial certificate illustrates: lot UNBT10 names Thymosin Beta-4 while the catalog describes the shorter fragment, which Marogen flags rather than resolving by assumption. Certificates are published by lot number at marogenbio.com/coa.

Identification and documentation
FieldWhat to require for these pens
Per-component identityMass for each: 663.4 NAD+, 2174.6 MOTS-c, 1419.5 BPC-157, 889 TB-500 fragment, 401.9 GHK-Cu, 342.4 KPV
Per-component purityA separate figure for each; a combined percentage says nothing about ratio
Per-component contentMilligrams of each, the only way a total means anything
Which TB-500 substanceThe Ac-LKKTETQ heptapeptide or thymosin beta-4, about 4,000 g/mol apart
Detection wavelengthNear 260 nm for NAD+, 214 or 220 nm for peptides
Concentration and fill volumeNot published for any pen. Require it against the lot number
Fill or release dateA pen is a dated solution, so age is part of the measurement
05

Storage and handling in the lab

All four are solutions, and the published formulation literature is consistent that a peptide in solution degrades faster than as a dry solid. Two add a complication. NAD+ is unstable in water and sensitive to pH, the least forgiving fill in the range. KLOW holds a copper complex alongside three peptides, and copper is an oxidation catalyst, so it is the one cartridge where a component works against its neighbours. The points below are general laboratory practice, not a Marogen specification.

  • Record the lot number and the release or fill date on receipt. For a solution, age is a variable.
  • Hold each pen at the temperature the supplier states, upright and out of light, and do not freeze a filled cartridge unless the supplier says it tolerates it.
  • Treat the MOTS-c cartridge as light-sensitive: a tryptophan and two methionines are three degradation handles in one peptide.
  • For Wolverine and KLOW the least stable component sets the limit, and in KLOW that is the copper complex.
06

Telling the four apart and matching them to vials

Each pen has a vial counterpart under the same product name, and the two are not interchangeable even when the name matches: one is a solid you weigh, the other a solution someone else made.

Telling the four apart and matching them to vials
PenIts counterparts and overlaps
NAD+ penAlso a vial in two sizes and a nasal spray. The only non-peptide in the pen range
MOTS-c penAlso a vial in three strengths and a nasal spray
Wolverine penAlso a vial in two sizes and a nasal spray, and the same pair as the BPC-157 and TB-500 blend
KLOW penAlso a vial. Shares three components with GLOW, minus KPV
07

What the published literature measured

No published literature covers these blends as blends; the measurements exist for the components. The four below are the primary record for the molecules in these cartridges.

  1. Imai S, Armstrong CM, Kaeberlein M, Guarente L. Nature 2000; 403:795-800.

    Measured deacetylase activity of the yeast Sir2 protein in vitro and showed the reaction consumes NAD+ as a cosubstrate, which is why NAD+ concentration is treated as a variable in sirtuin assays.

  2. Lee C, Zeng J, Drew BG, et al.. Cell Metabolism 2015; 21:443-454.

    Identified the open reading frame in mitochondrial 12S rRNA that encodes the 16-residue peptide, and reported the first metabolic measurements in cell and mouse models.

  3. Safer D, Elzinga M, Nachmias VT. Journal of Biological Chemistry 1991; 266:4029-4032.

    Showed by sequencing and co-chromatography that the actin-sequestering peptide then called Fx is thymosin beta-4, establishing the parent protein's identity.

  4. Pickart L, Thaler MM. Nature New Biology 1973; 243:85-87.

    Isolated the glycyl-histidyl-lysine tripeptide from human plasma and reported its effect on cultured liver cells, the paper that put GHK on record.

08

Wholesale availability

All four pens are supplied wholesale, priced per account rather than from a public list, and one pricing request can cover pens and their vial counterparts. For the two pens listed without a strength, and for both blends, ask for total content, concentration, fill volume and the per-component split against a lot number.

Apply for wholesale pricing

List the materials, sizes and units you need, or ask about the range, and say a little about the business. Pricing is set per account and confirmed on every quote, with the lot’s documentation status stated for each line.

09

Questions

What is in the KLOW pen?

Four molecules: GHK-Cu at 401.9 g/mol; BPC-157, the 15-residue GEPPPGKPADDAGLV at 1419.5; the TB-500 fragment Ac-LKKTETQ at 889; and KPV, Lys-Pro-Val at 342.4. The catalog publishes no total strength and no per-component split, so both need confirming on the quote.

What is in the Wolverine pen?

Two molecules: BPC-157 and the TB-500 fragment. The catalog copy says 10 mg of each, and Marogen's verification record flags that figure as needing confirmation against a certificate, because no public source can check it. The same pair is also sold as a vial, a nasal spray and the BPC-157 and TB-500 blend vial.

What should a certificate for a blend pen show?

Every component separately. For Wolverine that means two sets of observed and calculated mass, purity and content; for KLOW, four. A single purity percentage says nothing about the ratio, which is usually the figure that matters. It should also state which TB-500 substance is present, the heptapeptide at 889 g/mol or full-length thymosin beta-4 at roughly 4,963.

Why does NAD+ need a different detection wavelength?

Because it is not a peptide. Peptide purity is read by ultraviolet absorbance at 214 or 220 nm, where the backbone absorbs. NAD+ absorbs near 260 nm from its nucleotide bases, so a purity figure measured at 214 nm is the wrong channel.

Research use only. This guide describes materials supplied for in-vitro research and analytical method development. Nothing here is dosing, administration or use information, and no product on this site is offered for human or animal consumption. See the research use policy.